Grant of Restricted Stock to Employees and Officers and Employees of Subsidiaries
First written in FY2018-Q3. 11 of 13 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「15 January 2026 Paid third-party allotment of shares subject to transfer restrictions Total issue amount ¥30 million Transfer restriction period 15 January 2026–14 January 2031 Allottees and number of people and shares allotted Employees 33 people 9,900 shares Employees of subsidiaries 7 people 2,100 shares」
The company allotted a total of 12,000 shares subject to transfer restrictions to 33 employees and 7 employees of subsidiaries and continued operating the program. - 2026-05-22AdvancedGeneral Meeting of Shareholders
「発行済株式の総数の増加は、譲渡制限付株式付与制度における新株式発行による増加 12,000株であります。」
譲渡制限付株式付与制度により12,000株を新たに発行したことが示された。 - FY2024-Q3AdvancedAnnual report
「(Note) The issuance of new shares as restricted stock, with a payment date of 12 January 2024, increased the total number of shares issued by 20,100 shares and increased stated capital and capital surplus by ¥33 million each.」
Under the restricted stock program for employees and others, the Company issued 20,100 new shares with a payment date of 12 January 2024, increasing stated capital and capital surplus by ¥33 million each. - FY2023-Q3AdvancedAnnual report
「The issuance of new shares as restricted stock, with a payment date of 10 January 2023, increased the total number of shares issued by 12,300 shares and increased stated capital and capital surplus by ¥20 million each.」
The Company newly issued 12,300 restricted shares with a payment date of 10 January 2023, increasing stated capital and capital surplus by ¥20 million each. - FY2022AdvancedAnnual report
「Paid third-party allotment as restricted stock Total issue amount: ¥35 million Restriction period: 10 December 2021 to 9 December 2026」
In December 2021, the Company allocated a total of 8,700 restricted shares to 25 employees of the Company and 4 employees of subsidiaries, continuing operation of the program. - FY2022-Q3AdvancedAnnual report
「Third-party allotment as restricted stock Issue price: ¥4,120 per share Total issue amount: ¥35,844,000 Method of payment for contribution: Contribution in kind of monetary claims Increase in stated capital and capital surplus: Stated capital: ¥17,922,000 Capital surplus: ¥17,922,000 Restriction period: 10 December 2021 to 9 December 2026 Eligible recipients, number of recipients and number of shares allocated: Employees of the Company: 25 people, 7,500 shares Employees of the Company's subsidiaries: 4 people, 1,200 shares」
As of 10 December 2021, the Company allocated a total of 8,700 restricted shares to 25 employees of the Company and 4 employees of subsidiaries. The restriction period was from 10 December 2021 to 9 December 2026. - FY2021AdvancedAnnual report
「Other (disposal of treasury shares as restricted stock) during the fiscal year 148,069 403,191,887」
In fiscal 2020, the Company disposed of 148,069 restricted shares worth approximately ¥403 million for executive officers, employees and officers and employees of subsidiaries and others. - FY2021-Q3AdvancedAnnual report
「In December last year, the Company sought to strengthen its equity capital through the disposal of treasury shares by a third-party allotment to Tokyo Kiraboshi Financial Group,Inc., raising approximately ¥2.2 billion, as well as the implementation of approximately ¥400 million in restricted stock grants for all employees and others,」
The Company explained that it had made restricted stock grants worth approximately ¥400 million to employees and others. The existing stock grant program is also being used as a measure to strengthen the financial base. - FY2021-Q2AdvancedAnnual report
「Class and total number of shares to be disposed of: 148,069 shares of the Company's common stock Total disposal value: ¥403,191,887 Recipients, number of recipients and number of shares disposed of: 8 executive officers of the Company, 384 employees of the Company, 2 officers of the Company's subsidiaries and 17 employees of the Company's subsidiaries」
Pursuant to a resolution of the Board of Directors meeting held on 12 November 2020, the Company decided to dispose of 148,069 restricted shares with a total value of approximately ¥403 million for executive officers, employees and officers and employees of subsidiaries. - FY2020AdvancedAnnual report
「Other (disposal of treasury shares as restricted stock) 9,600 45,936,000」
During the fiscal year, the Company disposed of 9,600 treasury shares as restricted stock. The stock grant program for employees and officers and employees of subsidiaries continued to operate. - FY2019-Q3AdvancedAnnual report
「Issue price: ¥5,270 per share Total issue amount: ¥42,687,000 Method of payment for contribution: Contribution in kind of monetary claims Increase in stated capital and capital surplus: Stated capital: ¥21,343,500 Capital surplus: ¥21,343,500 Restriction period: 10 December 2018 to 9 December 2023 Eligible recipients, number of recipients and number of shares allocated: Employees of the Company and employees of the Company's subsidiaries: 27 people, 8,100 shares」
The Company issued 8,100 restricted shares through a paid third-party allotment to 27 employees of the Company and its subsidiaries. The restriction period was from 10 December 2018 to 9 December 2023. - FY2018AchievedAnnual report
「8 December 2017 to 7 December 2022」
The Company allocated restricted stock to employees, directors and employees of subsidiaries and others, issuing a total of 102,300 shares during the fiscal year. A restriction period was also established, completing the allocation under the program. - FY2018-Q3First statedAnnual report
「Paid third-party allotment as restricted stock Issue price: ¥5,530 per share Total issue amount: ¥555,765,000 Restriction period: 8 December 2017 to 7 December 2022 Eligible recipients, number of recipients and number of shares allocated: Employees of the Company and directors and employees of the Company's subsidiaries: 335 people, 100,500 shares」
The Company issued 100,500 shares through a paid third-party allotment to 335 employees of the Company and directors and employees of its subsidiaries. The restriction period was from 8 December 2017 to 7 December 2022.